Potential utility of PPARα activation in the prevention of ischemic and drug-induced acute renal damage

Kidney International

Volumn 76, Issue 10, 2009, Pages 1022-1024

  Lopez Hernandez, Francisco J ^a,b   Lopez Novoa, José M ^a  

^a Queen Sofia Institute of Nephrology Research   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; FATTY ACID;

ACUTE KIDNEY FAILURE; FATTY ACID OXIDATION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY PROXIMAL TUBULE; NONHUMAN; NOTE; PRIORITY JOURNAL; RENAL PROTECTION; REPERFUSION INJURY; ANIMAL; CHEMICALLY INDUCED DISORDER; GENETICS; METABOLISM; MOUSE; OXIDATION REDUCTION REACTION; PATHOLOGY; PATHOPHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; FATTY ACIDS, NONESTERIFIED; KIDNEY FAILURE, ACUTE; KIDNEY TUBULES, PROXIMAL; MICE; MICE, TRANSGENIC; OXIDATION-REDUCTION; PPAR ALPHA; REPERFUSION INJURY;

EID: 70350633113     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.229     Document Type: Note

References (13)

1. Sheridan AM, Bonventre JV . Pathophysiology of ischemic acute renal failure. Contrib Nephrol 2001; 132: 7-21.
2. Lameire N, Van Biesen W, Vanholder R Acute renal failure. Lancet 2005; 365: 417-430.
3. Launay-Vacher V, Rey JB, Isnard-Bagnis C et al. Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care . Cancer Chemother Pharmacol 2008; 61: 903-909.
4. Pabla N, Dong Z . Cisplatin nephrotoxicity: mechanisms and renoprotective strategies . Kidney Int 2008; 73: 994-1007.
5. Guan Y. Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome . J Am Soc Nephrol2004; 15: 2801-2815.
6. Lefebvre P, Chinetti G, Fruchart JC et al. Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis . J Clin Invest 2006; 116: 571-580.
7. Portilla D, Dai G, McClureTet al. Alterations of PPARaand its coactivator PGC-1 in cisplatin-induced acute renal failure . Kidney Int 2002;62: 1208-1218.
8. López-Novoa JM. Potential role of platelet activating factor in acute renal failure . Kidney Int 1999;55: 1672-1682.
9. Nagothu KK, Bhatt R, Kaushal GP et al. Fibrate prevents cisplatin-induced proximal tubule cell death . Kidney Int 2005; 68: 2680-2693.
10. Li S, Nagothu KK, DesaiVet al. Transgenic expression of proximal tubule peroxisome proliferator-activated receptor-a in mice confers protection during acute kidney injury . Kidney Int 2009; 76: 1049-1062.
11. Doi K, Suzuki Y, Nakao A et al. Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney . Kidney Int 2004; 65: 1714-1723.
12. LeeJYJeJHJungKJet al. Induction of endothelial iNOS by 4-hydroxyhexenal through NF-kappaB activation . Free Radic Biol Med 2004; 37: 539-548.
13. WenzT, DiazF,Spiegelman BM et al. Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype . Cell Metab 2008;8: 249-256 .